Minimal Clinically Important Difference on Parkinson’s Disease Sleep Scale 2nd Version
Background and Aims. The aim of the present study was to determine the estimates of minimal clinically important difference for Parkinson’s Disease Sleep Scale 2nd version (PDSS-2) total score and dimensions. Methods. The subject population consisted of 413 PD patients. At baseline, MDS-UPDRS, Hoehn...
Saved in:
| Main Authors: | Krisztina Horváth, Zsuzsanna Aschermann, Péter Ács, Gabriella Deli, József Janszky, Sámuel Komoly, Kázmér Karádi, Márton Kovács, Attila Makkos, Béla Faludi, Norbert Kovács |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Parkinson's Disease |
| Online Access: | http://dx.doi.org/10.1155/2015/970534 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deep Brain Stimulation Can Preserve Working Status in Parkinson’s Disease
by: Gabriella Deli, et al.
Published: (2015-01-01) -
Are Branded and Generic Extended-Release Ropinirole Formulations Equally Efficacious? A Rater-Blinded, Switch-Over, Multicenter Study
by: Edit Bosnyák, et al.
Published: (2014-01-01) -
Association of Gait Characteristics and Depression in Patients with Parkinson’s Disease Assessed in Goal-Directed Locomotion Task
by: Péter Kincses, et al.
Published: (2017-01-01) -
Is the MDS-UPDRS a Good Screening Tool for Detecting Sleep Problems and Daytime Sleepiness in Parkinson’s Disease?
by: Krisztina Horváth, et al.
Published: (2014-01-01) -
Small Fiber Neuropathy: Clinicopathological Correlations
by: Endre Pál, et al.
Published: (2020-01-01)